Detecting synaptic autoantibodies in psychoses: need for more sensitive methods.

Area of Science:

• Neuroscience
• Immunology
• Psychiatry

Background:

• Schizophrenia affects ~1% of the population, often leading to chronic disability.
• While treatments exist, they are palliative, not curative.
• Decreased N-methyl-D-aspartate (NMDA) receptor function is a common theme in psychosis.

Purpose of the Study:

• To investigate the role of auto-antibodies against NMDA receptors in schizophrenia.
• To address the limitations of current antibody detection methods.
• To explore potential new therapeutic targets for a subset of psychosis patients.

Main Methods:

• Review of existing studies on NMDA receptor antibodies in schizophrenia patients.
• Analysis of antibody detection methodologies and their limitations.
• Discussion of emerging evidence linking auto-immunity to psychosis.

Main Results:

• Previous studies found NMDA receptor antibodies in few schizophrenia patients or the general population.
• Current antibody detection methods may lack the sensitivity to identify relevant auto-antibodies.
• Auto-antibodies may be responsible for a subgroup of psychoses currently diagnosed as schizophrenia.

Conclusions:

• A significant proportion of psychosis patients may have an autoimmune component.
• Current diagnostic methods may fail to detect these auto-antibodies.
• Enhanced antibody detection research is crucial for identifying potentially treatable autoimmune psychosis.